Cargando…
Evaluating the efficacy and safety of percutaneous coronary intervention (PCI) versus the optimal drug therapy (ODT) for stable coronary heart disease: a systematic review and meta-analysis
BACKGROUND: Many studies have reported potential benefits of percutaneous coronary intervention (PCI) versus optimal drug therapy (ODT) for patients with stable coronary heart disease but with inconsistent results. To examine this, an explicit systematic review and meta-analysis was conducted to com...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9096285/ https://www.ncbi.nlm.nih.gov/pubmed/35572911 http://dx.doi.org/10.21037/jtd-22-222 |
_version_ | 1784705941507145728 |
---|---|
author | Qian, Xiaodong Deng, Haoze Yuan, Jiamin Hu, Junting Dai, Lujia Jiang, Tingbo |
author_facet | Qian, Xiaodong Deng, Haoze Yuan, Jiamin Hu, Junting Dai, Lujia Jiang, Tingbo |
author_sort | Qian, Xiaodong |
collection | PubMed |
description | BACKGROUND: Many studies have reported potential benefits of percutaneous coronary intervention (PCI) versus optimal drug therapy (ODT) for patients with stable coronary heart disease but with inconsistent results. To examine this, an explicit systematic review and meta-analysis was conducted to compared the clinical outcomes of PCI and ODT in these patients. METHODS: The following terms were combined to search relative articles through databases PubMed, Cochrane Central Register of Controlled Trials, Embase, and Web of Science published from January 2010 to November 2021 according to Participants, Intervention, Control, Outcomes, Study (PICOS) criteria: “coronary heart disease”, “stable coronary heart disease”, “stable angina pectoris”, “percutaneous coronary intervention”, “PCI”, “percutaneous transluminal coronary angioplasty”, “drug therapy”, “optimized drug treatment”, and “optimized drug therapy”. The meta-analysis was performed by RevMan 5.2, and the Cochrane risk of bias tool was used to evaluate the quality of the included studies. RESULTS: A total of 12 articles were included in the final analysis. There were 4,288 cases of PCI patients and 4,261 cases of ODT patients. The results showed that, when comparing PCI with ODT, there was a significant difference in the probability of myocardial infarction [relative risk (RR) =0.63; 95% confidence intervals (CI): 0.45–0.90] and the patient mortality (RR =0.51; 95% CI: 0.40–0.64). However, there was no significant difference in the prevalence of stroke (RR =1.33; 95% CI: 0.82–2.17), revascularization (RR =0.86; 95% CI: 0.46–1.62) and patient quality of life (MD =10.44; 95% CI: −1.84 to 22.73). Performance bias and detection bias were all unclear in the included studies and should be warned. DISCUSSION: Compared with ODT, PCI reduced the mortality and myocardial infarction rate of patients with CTO or severe coronary artery stenosis. However, the incidence of stroke, revascularization, and quality of life of patients were not significant different between PCI and ODT. Performance bias and detection bias should be cautioned. |
format | Online Article Text |
id | pubmed-9096285 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | AME Publishing Company |
record_format | MEDLINE/PubMed |
spelling | pubmed-90962852022-05-13 Evaluating the efficacy and safety of percutaneous coronary intervention (PCI) versus the optimal drug therapy (ODT) for stable coronary heart disease: a systematic review and meta-analysis Qian, Xiaodong Deng, Haoze Yuan, Jiamin Hu, Junting Dai, Lujia Jiang, Tingbo J Thorac Dis Original Article BACKGROUND: Many studies have reported potential benefits of percutaneous coronary intervention (PCI) versus optimal drug therapy (ODT) for patients with stable coronary heart disease but with inconsistent results. To examine this, an explicit systematic review and meta-analysis was conducted to compared the clinical outcomes of PCI and ODT in these patients. METHODS: The following terms were combined to search relative articles through databases PubMed, Cochrane Central Register of Controlled Trials, Embase, and Web of Science published from January 2010 to November 2021 according to Participants, Intervention, Control, Outcomes, Study (PICOS) criteria: “coronary heart disease”, “stable coronary heart disease”, “stable angina pectoris”, “percutaneous coronary intervention”, “PCI”, “percutaneous transluminal coronary angioplasty”, “drug therapy”, “optimized drug treatment”, and “optimized drug therapy”. The meta-analysis was performed by RevMan 5.2, and the Cochrane risk of bias tool was used to evaluate the quality of the included studies. RESULTS: A total of 12 articles were included in the final analysis. There were 4,288 cases of PCI patients and 4,261 cases of ODT patients. The results showed that, when comparing PCI with ODT, there was a significant difference in the probability of myocardial infarction [relative risk (RR) =0.63; 95% confidence intervals (CI): 0.45–0.90] and the patient mortality (RR =0.51; 95% CI: 0.40–0.64). However, there was no significant difference in the prevalence of stroke (RR =1.33; 95% CI: 0.82–2.17), revascularization (RR =0.86; 95% CI: 0.46–1.62) and patient quality of life (MD =10.44; 95% CI: −1.84 to 22.73). Performance bias and detection bias were all unclear in the included studies and should be warned. DISCUSSION: Compared with ODT, PCI reduced the mortality and myocardial infarction rate of patients with CTO or severe coronary artery stenosis. However, the incidence of stroke, revascularization, and quality of life of patients were not significant different between PCI and ODT. Performance bias and detection bias should be cautioned. AME Publishing Company 2022-04 /pmc/articles/PMC9096285/ /pubmed/35572911 http://dx.doi.org/10.21037/jtd-22-222 Text en 2022 Journal of Thoracic Disease. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) . |
spellingShingle | Original Article Qian, Xiaodong Deng, Haoze Yuan, Jiamin Hu, Junting Dai, Lujia Jiang, Tingbo Evaluating the efficacy and safety of percutaneous coronary intervention (PCI) versus the optimal drug therapy (ODT) for stable coronary heart disease: a systematic review and meta-analysis |
title | Evaluating the efficacy and safety of percutaneous coronary intervention (PCI) versus the optimal drug therapy (ODT) for stable coronary heart disease: a systematic review and meta-analysis |
title_full | Evaluating the efficacy and safety of percutaneous coronary intervention (PCI) versus the optimal drug therapy (ODT) for stable coronary heart disease: a systematic review and meta-analysis |
title_fullStr | Evaluating the efficacy and safety of percutaneous coronary intervention (PCI) versus the optimal drug therapy (ODT) for stable coronary heart disease: a systematic review and meta-analysis |
title_full_unstemmed | Evaluating the efficacy and safety of percutaneous coronary intervention (PCI) versus the optimal drug therapy (ODT) for stable coronary heart disease: a systematic review and meta-analysis |
title_short | Evaluating the efficacy and safety of percutaneous coronary intervention (PCI) versus the optimal drug therapy (ODT) for stable coronary heart disease: a systematic review and meta-analysis |
title_sort | evaluating the efficacy and safety of percutaneous coronary intervention (pci) versus the optimal drug therapy (odt) for stable coronary heart disease: a systematic review and meta-analysis |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9096285/ https://www.ncbi.nlm.nih.gov/pubmed/35572911 http://dx.doi.org/10.21037/jtd-22-222 |
work_keys_str_mv | AT qianxiaodong evaluatingtheefficacyandsafetyofpercutaneouscoronaryinterventionpciversustheoptimaldrugtherapyodtforstablecoronaryheartdiseaseasystematicreviewandmetaanalysis AT denghaoze evaluatingtheefficacyandsafetyofpercutaneouscoronaryinterventionpciversustheoptimaldrugtherapyodtforstablecoronaryheartdiseaseasystematicreviewandmetaanalysis AT yuanjiamin evaluatingtheefficacyandsafetyofpercutaneouscoronaryinterventionpciversustheoptimaldrugtherapyodtforstablecoronaryheartdiseaseasystematicreviewandmetaanalysis AT hujunting evaluatingtheefficacyandsafetyofpercutaneouscoronaryinterventionpciversustheoptimaldrugtherapyodtforstablecoronaryheartdiseaseasystematicreviewandmetaanalysis AT dailujia evaluatingtheefficacyandsafetyofpercutaneouscoronaryinterventionpciversustheoptimaldrugtherapyodtforstablecoronaryheartdiseaseasystematicreviewandmetaanalysis AT jiangtingbo evaluatingtheefficacyandsafetyofpercutaneouscoronaryinterventionpciversustheoptimaldrugtherapyodtforstablecoronaryheartdiseaseasystematicreviewandmetaanalysis |